
邦器生物
邦器生物
Biotech/Healthcare
Founded in 2020, Bangqi Biotechnology develops instruments and reagents for autoimmune and allergy diagnostics. The company has established a comprehensive product portfolio and assembled a full-industry-chain team covering R&D, manufacturing, registration and quality, supply chain, and sales…
Latest round: Series B (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.